DanCann Pharma A/S Publishes Q3-2024 Report: Steady Growth in Medicinal Cannabis Prescriptions Signals Promising Future for Patients
COPENHAGEN, Denmark, 22 November 2024 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby announce that the Company has published its report for the third quarter (Q3) of 2024. The Q3-2024 report is available as an attached document to this press release and at www.dancann.com.SUMMARY: GROUP KEY FIGURES Q3-2024 +-----------+----------+----------+----------+----------+-------------------+|DKK 1,000 |01/07/24 |01/07/23 |01/01/24 |01/01/23 |01/01/23 - 31/12/23|| |- 30/09/24|- 30/09/23|- 30/09/24|- 30/09/